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Aim: The efficacy of gadolinium (Gd) chelates as contrast agents for magnetic 
resonance imaging remains limited owing to poor relaxivity and toxic effects. Here, 
the effect of the hydration of the hydrogel structure on the relaxometric properties 
of Gd-DTPA is explained for the first time and called Hydrodenticity. Results: The 
ability to tune the hydrogel structure is proved through a microfluidic flow-focusing 
approach able to produce crosslinked hyaluronic acid nanoparticles, analyzed 
regarding the crosslink density and mesh size, and connected to the characteristic 
correlation times of the Gd-DTPA. Conclusion: Hydrodenticity explains the boosting 
(12-times) of the Gd-DTPA relaxivity by tuning hydrogel structural parameters, 
potentially enabling the reduction of the administration dosage as approved for 
clinical use.
First draft submitted: 30 March 2017; Accepted for publication: 14 June 2017; Published 
online: 17 August 2017
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During the past 30 years, magnetic reso-
nance imaging (MRI) has emerged as an 
established technique for preclinical imaging 
and clinical diagnosis [1–4]. Although MRI 
enables visualization of tissues at high spatial 
resolution without using ionizing radiation 
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or invasive procedures, its sensitivity is significantly 
lower than other imaging modalities, such as PET/
single-photon emission computed tomography [5–8]. 
Performances of MRI examinations can be improved 
by using contrast agents (CAs), which allow the dif-
ferentiation of tissues that would otherwise be indis-
tinct [9–11].
The presence of the CA causes a significant increase 
in the relaxation rate of the water proton nearby para-
magnetic ions, thereby adding details to the anatomical 
resolution. Thanks to its very high magnetic moment, 
gadolinium (Gd) is the most frequently used metal ion 
for MRI. However, owing to the toxicity of free Gd 
ions [6], which can induce nephrogenic system fibrosis, 
Gd-chelates, such as Gd-DTPA (Magnevist, Schering 
AG) [12], are commonly used in contrast-enhanced 
examinations [5,13].
Currently, more than 35% of all clinical MRI scans 
utilize the injection of clinically approved Gd-based 
CAs (GdCAs) intra venously [5]. Despite this wide-
spread use, some concerns arise from CAs’ efficacy, 
mainly limited by their concentration (mM) and relax-
ivity (r
1
, mM-1s-1). Other concerns are related to low tis-
sue specificity, nephrotoxicity, long scan time and rapid 
renal clearance, which significantly reduce the time 
window for clinical imaging acquisitions [14,15]. Fur-
thermore, McDonald et al. [16] have recently reported 
results about intracranial Gd deposition after repeated 
intravenous administration of CAs even if these signal 
intensity changes are not specific and can be seen with 
several other pathologic conditions.
The poor relaxivity of commercial CAs, much 
below its theoretically maximal value [17,18], has led to 
the development of novel macromolecules conjugat-
ing CAs [1,19–24]. As stated by Solomon–Bloember-
gen–Morgan theory [25,26], indeed, high relaxivity can 
be achieved by controlling the characteristic param-
eters that regulate the dipolar interaction between 
water protons and GdCAs [5]. The main characteristic 
parameters include: the number of water molecules 
(q) in the inner sphere, in other words, those present 
in the coordination sites of the Gd ion and their resi-
dence lifetime (Τ
M
); the rotational correlation time of 
the metal complex (Τ
R
); the diffusion correlation time 
(Τ
D
) of the water molecules in the outer sphere, in other 
words, those diffusing nearby the metal  complex.
These parameters can be tuned by exploiting the 
versatile properties of nano- and bio-materials and 
a wide range of nanostructured CAs with enhanced 
relaxivity can be developed [17,27–33]. We have recently 
published some works in this field explaining the 
impact of biopolymer matrices on relaxometric prop-
erties of CAs [34] and showing a microfluidic approach 
to produce hydrogel nanoparticles loading clinically 
relevant GdCAs, improving relaxometric properties of 
CAs without their chemical modification [35]. Other 
authors also proposed some strategies to fabricate 
nanostructures based on the effect of rigidification [36] 
and confinement [37] of metal-chelates [38] to boost 
relaxometric properties [39].
Despite the valuable role of the CAs for MRI, this 
case history confirms the importance of developing 
systems able to enhance relaxivity of clinical relevant 
GdCAs and also to protect the chelate from trans-
metallation phenomena and control accumulation and 
clearance in a specific organ [40–42].
In this scenario, we have proved that, by changing 
structural parameters of an hydrogel matrix contain-
ing a CA through a microfluidic flow-focusing (MFF) 
approach, it is possible to affect the dipolar coupling 
between the electronic magnetic moment of the metal 
ion and the nuclear magnetic moment of the water 
protons (relaxation rate). This effect results from 
the complex equilibrium established by the elastic 
stretches of polymer chains, water osmotic pressure 
and hydration degree of GdCAs, that we have called 
Hydrodenticity.
Hydrodenticity, hence, refers to the status of the 
hydrated Gd-DTPA with the coordination water sub-
jected to osmotic pressure [43] deriving from elastody-
namics equilibrium of swollen gels [44–46]. We hypoth-
esize that the attainment of this equilibrium is reached 
when the normal energetic stability of the meshes is 
compromised by the presence of the Gd-DTPA and 
evolves to a new spontaneous equilibrium involving the 
formation of nanocompartments, here called ‘Gado-
Meshes’, in which water is in an abnormal aggregate 
state that influences the relaxivity. The capability to 
control the organization of these nanocompartments 
within the nanoparticles can be applied to define a new 
class of medical products useful to improve the proper-
ties of CAs for MRI.
The tunability of the hydrogel properties is here 
achieved by a microfluidic adjustable and high-through-
put strategy, already proposed to produce intravascu-
larly-injectable and biocompatible Gd-DTPA-loaded 
crosslinked hyaluronic acid nanoparticles (cHANPS) 
for MRI [35]. Within the cHANPs, the properties of 
Hydrodenticity can be modulated to obtain desired 
crosslink density, mesh size, hydrophilicity and loading 
capability, playing on the biodegradable behavior and 
relaxometric properties of the Gd-loaded cHANPs. 
Indeed, nanoparticles with a mean particle size as low 
as 35 nm are obtained without the chemical modifi-
cation of the clinically approved chelate, achieving a 
signal intensity in r
1
 12-times larger than that of the 
commercial MRI CA, Magnevist, at the magnetic field 
used in clinical MRI, 1.5 Tesla.
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Materials & methods
Materials
Sodium hyaluronate (Mw = 42 kDa) is purchased 
from Bohus Biotech (Sweden). Diethylenetri-
aminepentaacetic acid gadolinium(III) dihydro-
gen salt hydrate Gd-DTPA (empirical formula: 
C
14
H
2
OGdN
3
O
10
×H
2
O; Mw = 547.57 g/mol). Non-
ionic surfactant Span80 (formula C
24
H
44
O
6
 formula 
weight: 428.62 g/mol). Divinyl sulfone (or vinyl sul-
fone) (DVS) contains <650 p.p.m. hydroquinone as 
inhibitor (purity 97%; density 1.117 g/ml at 25°C 
(lit.); molecular formula: C
4
H
6
O
2
S; Mw = 118.15 g/
mol). Acetone (CHROMASOLV, for HPLC ≥99.8; 
molecular formula: CH
3
COCH
3
; Mw = 58.08 g/mol). 
Ethanol (ACS reagent, ≥99.5 [200 proof], absolute; 
molecular formula: CH
3
CH
2
OH; Mw = 46.07 g/mol). 
Sodium hydroxide NaOH (ACS reagent, ≥97.0%, 
Mw = 40.00 g/mol). Gadolinium chloride solution 
GdCl
3
 (Mw = 263.61 g/mol) and sodium chloride 
NaCl (ACS reagent, ≥99.0%, Mw = 58.44 g/mol) are 
purchased from Sigma-Aldrich Co. The water, used for 
synthesis and characterization, is purified by distilla-
tion, deionization and reserve osmosis (Milli-Q Plus).
Microfluidic set-up for flow-focusing approach
Our microfluidic device ‘Droplet Junction Chip’ 
(depth × width 190 μm × 390 μm) is purchased from 
Dolomite Centre Ltd. It is a glass microfluidic device 
designed for generating droplets. The internal surface 
of the channel is coated with the hydrophobic mate-
rial. On the chip there are two separate droplet junc-
tions (see Supplementary Figure 1), which can be used 
in combination. For our experiments, we used only 
X-junction with three inlet channels and a single out-
let channel that can be used to mix and react three 
reagents. The device has a flow-focusing geometry 
with 90° angle between the inlets to enhance the dif-
fusion process. It is compatible with Chip interface H 
for fluidic connections. Three-way isolation ethylene 
tetrafluoroethylene valves, connected to the syringes 
and the microfluidic device, make the automatic fill-in 
of the syringes feasible, thus allowing a continuous dis-
pensing of reagents. The linkage between fluorinated 
ethylene propylene tubes and device is carried out 
through a specially designed connection with polytet-
rafluoroethylene connectors. The flow focusing behav-
ior on the microchannel is observed using an optical 
fluorescence microscope (Olympus IX71) with a 4× 
scanning objective.
Microfluidic route of production & 
characterization
Multiple factors influencing the production process of 
cHANPs through the microfluidic platform have been 
evaluated in a previous publication [35]. Main steps of 
this protocol and furthers used in the present work are 
summarized here:
•	 Flow rate ratio: ratio between the solvent volumet-
ric flow rate and the nonsolvent volumetric flow 
rate (see paragraph “Preparation of nanoparticles” 
and Supplementary Information);
•	 Crosslinking strategy: premix of divinyl sulfone 
into the middle channel or adding DVS into the 
side channels (see paragraph “Crosslinking reaction 
by DVS” and Supplementary Information);
•	 Effect of crosslinking agent’s concentration, pro-
cess temperature, type of surfactant, NaOH and 
NaCl concentration and other parameters have 
been widely discussed in our previous work [35].
After the nanoparticles’ synthesis, further properties of 
cHANPs are also evaluated:
•	 Loading capability (see paragraph “Loading capa-
bility” and Supplementary Information);
•	 Stability in water (see paragraph “Stability and 
release study of cHANPs” and Supplementary 
Information);
•	 Longitudinal relaxation times, rates and relaxivity 
(see paragraph “In vitro relaxivity study” and Suppl-
ementary Information);
•	 Swelling ratio (SR) (see paragraph “Swelling ratio 
and hydrogel parameters” and Supplementary 
Information).
Finally, the following hydrogel structural parameters 
are theoretically computed and their relationships with 
relaxation parameters are evaluated:
•	 Crosslink density (see paragraph “Swelling ratio 
and hydrogel parameters” and Supplementary 
Information);
•	 Mesh size (see paragraph “Swelling ratio and hydro-
gel parameters” and Supplementary Information).
Preparation of nanoparticles
Different flow rates are tested and the influence of 
the flow rate ratio is determined. For the feasibility 
study, a 5 ml aqueous solution containing hyaluronic 
acid (HA), concentrations ranging from 0.01 to 0.1% 
w/v, is used to examine the effect of the nanoprecipita-
tion by flow focusing only due to the concentration of 
the polymer. Higher HA concentrations provide mas-
sive precipitation, causing a strong interference on the 
flow focusing and consequently on the nanoparticle 
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size. Among several tested molecular weights of HA, 
42 kDa is selected as the optimal one because it can 
provide smaller nanoparticles. The initial solution is 
kept under continuous stirring for at least 4 h and then 
injected through the middle channel. The middle flow 
rate is ranged from 5 to 100 μl/min. A nonsolvent, 
in other words, acetone as suggested elsewhere [47], 
is injected through the side channels to induce nano-
precipitation by a flow-focusing approach. Side flow 
rates are changed from 50 to 300 μl/min, with a step 
of 10 μl/min. Precipitated nanoparticles are collected 
in a Petri glass containing few milliliters of nonsolvent 
and kept under continuous stirring. The stirring, con-
ducted over 8 h, is used to promote the diffusion of 
DVS and consequently to improve the crosslinking 
reaction. Each experiment is repeated many times.
Crosslinking reaction by DVS
Crosslinking reaction by DVS is studied in the micro-
fluidic system at a concentration of NaOH and NaCl 
ranging from 0.1 to 0.3 M and from 0.02 to 0.2 M, 
respectively. Acetone, ethanol and isopropanol are 
tested as nonsolvent and are introduced in the side 
micro-channels, as already explained in our previous 
work [35].
Two crosslinking scenarios are investigated: premix 
of DVS into the middle channel or adding DVS into 
the side channels. The crosslinking agent is injected, 
alternatively, into the side channels or in the middle 
channel at different concentrations, ranging from 0 to 
8% v/v and from 0 to 20% v/v, respectively.
Three different surfactants are tested at various 
reagent concentrations and flow rates. Tween-85 (rang-
ing from 0.5 to 1% w/v), Tween-21 (ranging from 0.5 
to 3% w/v) and Span 80 (ranging from 0.5 to 1.5% 
w/v), are mixed to the nonsolvent or to the aqueous 
solution. In the first scenario, the solvent phase also 
containing DVS is kept at a constant T of 5°C to avoid 
undesired crosslinking effects; the device is instead 
heated to 35°C.
Purification, recovery and characterization of 
nanoparticles
Purification is performed by a solvent gradient dialysis 
or by ultracentrifugation. Typically, 2 ml of the pro-
duced nanoparticles are collected and used for further 
analysis and size characterization. A Spectra Por Cellu-
lose Membrane 6 (Molecular Weight Cut Off MWCO 
50,000) is used for purification protocol. A typical pro-
cedure consists of loading collected samples into dialy-
sis tube and keeping the buffer solution (phosphate-
buffered saline [PBS], pH 6.8, room temperature; final 
concentration of 10 mM PO
4
3-, 137 mM NaCl and 
2.7 mM KCl) under continuous stirring at 130 r.p.m. 
to increase the diffusion rate. The first purification step 
is in ethanol:
•	 Purify the sample for 2 h in 70% Acetone + 30% 
Ethanol; 2 h in 50% Acetone + 50% Ethanol; 2 h 
in 30% Acetone + 70% Ethanol; 2 h in 100% 
Ethanol.
The second purification step is in water:
•	 Purify the sample for 2 h in 70% Ethanol + 30% 
MilliQ water; 2 h in 50% Ethanol + 50% MilliQ 
water; 2 h in 30% Ethanol + 70% MilliQ water; 
2 h in 100% MilliQ water.
The concentration gradient of water is slowly added 
to the buffer solution to avoid aggregation and dif-
fusion phenomena across the membrane. Dynamic 
light scattering is used to determine nanoparticle size. 
Nanoparticles are concentrated by ultracentrifugation. 
The recovery is performed at 15°C, at 80,000 r.p.m. 
for 15 min. After these treatments, a 100 μl of puri-
fied samples are deposited on a polycarbonate Isopore 
membrane filter (0.05, 0.1 and 0.2 μm) by ultrafiltra-
tion vacuum system. The precipitated or deposited par-
ticles are gold palladium coated and an ULTRA PLUS 
field emission scanning electron microscope (FE-SEM 
Carl Zeiss, Germany) is used to observe particles’ 
morphology. Transmission electron microscope and 
Cryo-transmission electron microscope is also used to 
characterize the samples. It is worth highlighting that 
all nanoparticles are purified in ethanol to remove par-
tially the unreacted reagents and to allow us the SEM 
characterization deposing the sample on a polycarbon-
ate Isopore membrane filter (0.015, 0.05 and 0.1 μm) 
by ultrafiltration vacuum system.
Loading capability
Loading capability is calculated collecting data 
by induced coupled plasma (ICP-MS), NexION® 
350 Perkin Elmer Spectrometer. Nanoparticles are sus-
pended in a solution of deionized water at a concentra-
tion of 250,000 particles/ml. Nanoparticles tracking 
analysis is used to calculate the number of nanopar-
ticles (see Supplementary Figure 9). An acid compound 
is not added to avoid dissolution of the nanoparticles. 
All data are collected and processed using the Syngistix 
Nano Application Module. Gd is measured at m/z 157 
using a 100 μs dwell time with no settling time.
The lyophilization of cHANPs is performed using 
a freeze-dryer Christ, 1–4LSC. Briefly, a freezing step 
for 3 h at -8°C with a cooling profile of 1°C/min is 
applied, sublimation at a shelf temperature of 6°C and 
pressure of 0.85 mbar for at least 24 h and finally, sec-
ondary drying at 25°C and 0.03 mbar for 5–6 h. Tre-
halose or sucrose ranging from 1 to 3% w/v is added 
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as cryoprotector if necessary for resuspension. Dried 
particles are also observed by FE-SEM.
Stability & release study of cHANPs
The Gd-DTPA loaded cHANPs are mixed with 
150 μl of PBS. The nanoparticles are kept shaking at 
100 r.p.m. at 37°C. The solution is divided into two 
equal parts at 4, 12, 24, 48, 96 and 172 h post incuba-
tion. One-half of the solution is assessed by ICP-MS 
for the total concentration of Gd3+ ions loaded within 
the nanoparticles. The other half of the solution is fil-
ter-spun using 0.45 μm filter columns at 14,000 r.p.m. 
for 5 min and the filtrate is analyzed for Gd3+ ions. The 
two concentrations are compared and the amount of 
Gd3+ ions released over time is determined. To assess 
the long stability of the nanoparticles, only conditions 
that do not produce a swelling behavior are tested. The 
release profile of Gd-DTPA is measured at different 
time points, namely 12, 24 and 48 h both in water and 
under two physiologically relevant conditions, namely 
stationary and constant shaking in PBS (pH = 7.4, 
37°C).
In vitro relaxivity study
Empty nanoparticles and nanoparticles containing 
Gd-DTPA at different concentrations are tested by 
in vitro MRI and results are compared with Magnev-
ist, Gd-DTPA in water as a control. After vigorously 
stirring, changes in longitudinal relaxation time (T
1
) 
are evaluated at 1.5 T by Minispec Bench Top Relax-
ometer (Bruker Corporation), adding 300 μl of the 
sample to a specific tube. Only results about T
1
 will 
be reported. Finally, relaxivity r
1
 is calculated using 
weighted linear regression (R
1
=1/T
1
 s-1 relaxation rate 
plotted against Gd concentration, mM and r
1
, mM-1 s-1, 
is the slope of the fitted curve). Estimation of mea-
surement uncertainty is evaluated using weighted 
linear regression. Furthermore, the relaxation time 
distribution was obtained by CONTIN Algorithm. 
The relaxation spectrum was normalized with respect 
to the CONTIN processing parameters. The integral 
of a peak corresponds therefore to the contribution of 
the species exhibiting this peculiar relaxation to the 
 relaxation time spectrum.
Swelling ratio & hydrogel parameters
SR is calculated with Equation 1:
SR
d
d
H O
eth
= 2
where d
eth
 (in nm) d
H2O
 (in nm) are the nanoparticle’s 
diameters in ethanol and in water respectively (for fur-
ther details about the SR calculation please refer to the 
Supplementary Information at the paragraph ‘Calcula-
tions of the hydrogel network parameters’), measured 
by dynamic light scattering. A simplified version of the 
the Flory–Rehner equations are used in order to com-
pute the hydrogel structure parameters (Mc: Molecular 
weight between crosslinks (g/mol); ν
e
: Effective cross-
link density (mol/cm3); ξ: Mesh size (nm)). See 
Supplementary Information for detailed calculations of 
the hydrogel network parameters.
Results
Preparation of cHANPs
MFF systems have already been explored for the pro-
duction of polymer micelles and nanoparticles [48,49]. 
However, an investigation of the opportunity that this 
approach could bring to the MRI field, given the impact 
of the hydrogel behavior on the relaxometric proper-
ties, is still missing. We have recently demonstrated 
that, through the microfluidics, it is possible to produce 
stable hydrogel nanoparticles with improved relaxomet-
ric properties [35]. Briefly, by changing the relative flow 
rates and the concentration of the species in the streams, 
we can control nanoprecipitation phenomena [49–51] 
and achieve the formation of small nanoparticles (see 
Supplementary Table 1 & Figure 2). In our system, start-
ing from an HA 0.05% w/v solution, monodisperse 
nanoparticles smaller than 40 nm are obtained (see 
Supplementary Figure 2B & C). Subsequently, a cross-
linking reaction is performed together with the forma-
tion of nanoparticles using DVS [52–55] as crosslinking 
agent at standard flow conditions. In the same work [35], 
we have also reported two effective crosslinking scenar-
ios to explore and control the nature of the interference 
(see Supplementary Figure 3 & Table 2) between the Gd-
DTPA and the flow-focused nanoprecipitation: premix-
ing of DVS into the middle channel at controlled tem-
perature and surfactant concentration; addition of DVS 
to the side channels by strictly controlling pH conditions. 
Both strategies, exploited through the microfluidic plat-
form, have been already reported [35] and further details 
in terms of crosslinking reaction and loading capability 
are reported in the Supplementary Figure 4 & Table 3. 
Results showing cHANPs with different concentration 
of NaOH and NaCl and different types of surfactants 
are already reported in our previous publication [35]. 
Briefly, spherical and stable nanoaprticles are obtained 
for both strategy but the addition of DVS to the middle 
channel and the use of surfactants produce a smaller size 
down to 35 nm.
Swelling behavior & hydrogel structural 
parameters of cHANPs
Here, starting from results in terms of the SR, cross-
link density and mesh size of the cHANPs contain-
ing Gd-DTPA are discussed, aiming to evaluate the 
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 2205
Figure 2. In vitro magnetic resonance imaging and effect of the hydrodenticity. (A) Longitudinal relaxation rate (1/T1) versus Gd-DTPA 
concentration for (--) free Gd-DTPA in water and for Gd-DTPA loaded cHANPs at different crosslink densities (-•- 7.6 × 10 -4 and  
-▪- 4.6 × 10-4 mol/cm3), showing a relaxivity of 3.9, 14.09 and 48.97 mM-1s-1, respectively. (B) Longitudinal relaxation time distribution 
for cHANPs at different crosslink densities. (C) Bar chart of longitudinal relaxivity (gray columns) and mesh size (blue columns) values 
for cHANPs at different crosslink densities. (D) Mesh size versus crosslink density (-▪-) and corresponding relaxivity values (--) along 
with a graphical representation of cHANPs’ polymer network at different mesh size values. 
cHANP: Crosslinked hyaluronic acid nanoparticle.
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modulation of the hydrogel structure in the presence 
of Gd-DTPA.
As far as the swelling behavior of the nanopar-
ticles, results at different DVS amounts are reported 
in Figure 1A and presented in terms of SR, as defined 
in the Methods section. Results clearly show that, 
nanoparticles are stable and do not exhibit a significant 
swelling behavior until 48 h at all explored DVS con-
ditions (see also Supplementary Figures 5 & 6). In par-
ticular, smallest nanoparticles of about 70 and 50 nm 
measured in water are only produced at DVS of 0.8 
and 4% v/v, respectively. For these two conditions, 
an increase in size up to 125 nm for 0.8% DVS and 
115 nm for 4% DVS is detected only after 1 week (see 
Supplementary Table 4).
Then, according to Flory–Rehner calcula-
tions [56], we have determined the crosslink den-
sity (ν
e
) and mesh size (ξ) of cHANPs in water after 
48 h (see Supplementary Table 5). It has been already 
reported [53] that lower molecular weight films gave 
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rise to decreased molecular weights between crosslinks 
as well as increased effective crosslink densities and 
decreased mesh size, thereby indicating a more stable 
structure. Even our results show that a general increase 
of the crosslink density of the cHANPs corresponds 
to an increase in the nanostructure stability, in other 
words, lower swelling ratio (Figure 1B). Furthermore, 
as expected, by increasing the crosslink density, a 
reduction in mesh size is also obtained until to a cer-
tain extent (Figure 1C).
FE-SEM images of cHANPs at 0.8% DVS (middle 
channel) and 4% DVS (side channels) after 48 h in 
water are reported in Figure 1D, E & F. Higher DVS 
concentrations cause formation of large aggregates, as 
shown in Supplementary Figure 4A & B. It is important 
to highlight that cHANPS are potentially safe and bio-
compatible; indeed, even if DVS is highly reactive and 
toxic, HA-DVS biocompatibility has been confirmed 
by histological analysis, as previously reported by Oh 
et al. [57].
In vitro relaxometric properties
The relationship between the measured structural 
parameters of the hydrogel and changes in CA’s relax-
ivity is also examined (Figure 2).
Given the versatility of the produced cHANPs, it 
is of particular interest to investigate how different 
reaction’s strategies and formulations could result in 
advanced and tailorable CA-loading functionalities. 
In vitro relaxivity is studied for loaded and unloaded 
cHANPs and the results are presented for Gd-DTPA 
in water at different concentrations. For all magnetic 
resonance (MR) experiments, T
1
 values measured on 
loaded cHANPs show a higher relaxation rate com-
pared with the relative ‘free’ CA, confirming that 
active compounds are not only dispersed or encapsu-
lated but even wrapped within the hydrogel polymer 
matrix of cHANPs. Besides, it is observed that the 
hydrogel structural parameters, in other words, cross-
link density and mesh size, can affect not only the 
stability and degradation behavior but also the MR 
functionality of the produced nanoparticles. Indeed, 
loaded cHANPs with different crosslink densities 
show a relaxivity (r
1
) of about 48.97 and 14.09 mM-
1s-1, respectively (Figure 2A, squares and circles). 
Both values are considerably higher than the value 
of 3.9 mM-1s-1 reported for commercial Magnevist 
(Figure 2A, triangles).
Additionally, a change in the crosslink densities of 
cHANPs causes differences in longitudinal relaxation 
time distributions (Figure 2B). A narrow distribu-
tion is obtained at a crosslink density of about 4.62 
× 10-4 mol/cm3, reflecting optimal equilibrium con-
ditions able to boost the MRI signal. Contrary to 
expectations, further increase in the crosslink density 
does not allow a sharper relaxation time distribution, 
even at smaller mesh sizes. As shown in Figure 2C, 
in fact, even if the mesh sizes computed at two dif-
ferent crosslink densities are quite similar (1.5 and 
2 nm for crosslink densities of 7.64 × 10-4 and 4.62 
× 10-4 mol/cm3, respectively), the highest relaxivity is 
not observed at the maximum crosslink density. This 
observation strenghtens the hypothesis that an optimal 
equilibrium among the species should be achieved in 
order to boost the relaxometric properties and that the 
hydrogel structure plays a critical role in the relaxation 
 enhancement (see Figure 2D).
For completeness, we have also evaluated the relax-
ivity of unloaded cHANPs and cHANPs entrapping 
Gd-DTPA by sorption and compared with free Gd-
DTPA in water (see Supplementary Figures 7 & 8).
The comparison of MRI relaxivity values acquired 
for cHANPs and free Gd-DTPA supports our ini-
tial hypothesis made on Hydrodenticity, revealing the 
opportunity to select specifically the optimal range 
of conditions that promotes relaxation enhancement 
(Figure 2D). Hence, the high relaxivity is attributed to 
the equilibrium simultaneously achieved between the 
water content within the hydrogel structures, expelled 
or retained during nanoprecipitation and crosslinking 
reaction, and the amount of Gd-DTPA entrapped in 
the formed matrix.
Discussion
By the above reported experiments, we have proved that 
a systematic and accurate tunability can be achieved 
by varying the crosslinking degree of the hydrogel 
nanoparticles in the presence of Gd-DTPA. A nar-
row or a broad distribution of relaxation rates on the 
crosslink density is showed with regards to changes in 
the water dynamics, hydrogel conformation and slow 
motion of the CAs. High control of these parameters is 
mainly reached through a MFF approach [35].
Starting from the observation of a peculiar swelling 
behavior (Figure 1A) and in vitro relaxometric proper-
ties of the cHANPs (Figure 2), we propose an expla-
nation, through a modified Flory–Rheiner theory, of 
how the hydrogel structural parameters can be used to 
improve the relaxometric properties of CAs [53].
Results show that Hydrodenticity can be proposed as 
a new concept to summarize the complex equilibrium 
formed by elastic stretches of polymer chains, water 
osmotic pressure and hydration degree of GdCAs able 
to boost the relaxivity.
Indeed, at the achieved minimum mesh size, cross-
link density is responsible for the elastodynamic of the 
hydrogel and is representative of the water amount 
within the polymer meshes, which in turn is related 
 2207
Figure 3. Hydrodenticity to enhance relaxivity. Schematic illustration of an improved diagnostic window in which 
it is possible to obtain a medical device for clinical use in the MRI field able to overcome the limitations related to 
the use of commercial CAs such as low relaxivity, limited acquisition time and reduced tissue specificity. 
CA: Contrast agent; MRI: Magnetic resonance imaging.
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to the osmotic pressure. Our results also show that the 
reduction in the elasticity of the matrix by increasing 
the crosslink density does not correspond to a maxi-
mum enhancement of the relaxivity (see Figure 2D). It 
is probably due to the expelled water from the hydrogel 
network [54] that causes a reduction in the osmotic pres-
sure within the water compartments of the meshes and 
a decrease of the hydrated status of Gd-DTPA, thus 
limiting the enhancement of the relaxometric proper-
ties in the nanostructures. These conditions promote 
the formation of water compartments containing Gd-
DTPA called ‘Gado-Meshes’.
It is also well-known that the crosslink density acts 
on the water diffusion, which decreases when the cross-
link density increases and its slowdown in diffusion is 
more severe at the polymer–water interface [58,59]. Even 
in the Gd-loaded cHANPs, the water diffusion at 
various crosslink densities is correlated with the water 
hydrogen bonding dynamics and the variation of dif-
fusion coefficient with crosslink density is related to 
the variation of water content in different crosslink 
densities. Therefore, by changing further the proper-
ties of the ‘Gado-Meshes’ through the crosslinking 
reaction, relaxivity increases to an even greater extent 
due to the Hydrodenticity because of the tuning of the 
crosslink density and, consequently, of the aggregated 
water state and slow moving of the CAs.
As the Hydrodenticity of CAs within the Gado-
Mesh does not involve the chemical modification of 
the CAs, the observed enhancement in relaxivity is 
induced by the synergistic interaction of the aggre-
gated water with the hydrogel matrix and Gd-DTPA. 
Indeed, according to the Solomon–Bloembergen–
Morgan theory, this effect promotes both (§) a further 
reduction of the water mobility and diffusion, induc-
ing an increase of the residence lifetime and charac-
teristic diffusion time (Τ
D
) of inner and outer sphere 
water molecules; and (§§) changes in hydrogel struc-
tures leading to the formation of nanocompartments 
enwrapping GdCAs, causing a slow motion of the CAs 
and, therefore, an increase of the rotational correlation 
time of the chelate. Furthermore, it is reasonable that 
the conditions reached in the Gado-Mesh can con-
trol the water exchange and therefore, the relaxivity. 
Indeed, relaxivity can be limited if the water exchange 
is too slow because the relaxation effect is poorly trans-
mitted to the bulk. However, relaxivity can also be 
reduced if the water exchange is too fast because the 
water is not coordinated to the GdCAs long enough to 
be relaxed [60].
In the proposed system, at some degree of Hydro-
denticity, the hydrated status of Gd complexes, the 
elastodynamic response of HA and the osmotic pres-
sure results probably in a much slower rotation. At 
this point, the importance of water exchange becomes 
significant, but the improved relaxivity of Gd-loaded 
cHANPs confirms that water diffusion is high enough 
and the process for relaxing the water protons of 
aggregated water is in any case very efficient. Finally, 
the relaxation time measurements clearly demonstrate 
how cHANPs themselves do not contribute to the 
relaxivity of the system (see Supplementary Figure 8). 
Thus, the increase in the relaxivity of the loaded 
cHANPs can be attributed solely to the formation of 
the Gado-Mesh and to the Hydrodenticity achieved 
in their organization that influences the relaxivity 
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through the  characteristic correlation times above 
mentioned.
Modulation of the Hydrodenticity through the elas-
tic stretching of the polymer meshes, osmotic pressure 
and hydrated state of Gd-DTPA contributes to the 
changes of the inner and outer sphere mechanisms of 
the CAs. Therefore, through the hydrogel structural 
parameters, we can produce a library of functional 
nanostructures on the needs of a particular pathol-
ogy, field and material properties. Results could lead to 
the identification of a personalized diagnostic window 
(Figure 3) that can define the range of optimal proper-
ties between the hydrogel matrix and the CAs, being 
more efficient in treating a particular disease, avoid-
ing toxic effects and increasing the performance of the 
MRI acquisitions.
Conclusion
The introduction of the Hydrodenticity creates sig-
nificant opportunities in controlling the behavior of 
metal chelates without their chemical modifications. 
It enables the increase of the relaxometric proper-
ties of the CAs preserving the chemical structures as 
approved for the use in the clinical practice. The pos-
sibility to increase the sensitivity of the CAs represents 
an opportunity to reduce the administration dosage 
currently in use.
Furthermore, Gd-loaded cHANPs based on the 
concept of Hydrodenticity are candidate to become 
an important nanomedicine tool to be tested in this 
direction, exhibiting a relaxivity value of ∼48.9 and 
∼14.02 mM-1s-1. Additionally, cHANPs have an aver-
age diameter of about 35 nm, do not swell nor degrade 
for at least 48 h under shaking. Further benefits can 
be found in: the possibility to be decorated chemically, 
becoming suitable for a specific target; the direct clini-
cal application, due to the utilization and improvement 
of biocompatible and US FDA approved products with-
out their chemical modifications; the ease of the syn-
thesis; the nature of the materials; and the scalability 
of the proposed process. In the future, the concept of 
Hydrodenticity could inspire other applications and be 
extended to different molecules and field of  knowledge.
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Summary points
• Clinically used contrast agents (CAs) for magnetic resonance imaging still suffer from poor sensitivity, low 
relaxivity and risk of metal ion deposition.
• We showed how hydrogel materials could respond to the dual need of protecting those CAs from 
transmetallation and at the same time, significantly improve their efficacy.
• We adopted a microfluidic flow focusing approach to produce crosslinked hyaluronic acid nanoparticles 
(cHANPs) that encapsulate gadolinium (Gd)-DTPA without chemically modifying its structure and 
biocompatibility.
• Swelling and relaxometric properties of the cHANPs were measured and studied using different techniques, 
from scanning electron microscopy and dynamic light scattering to time-domain nuclear magnetic resonance 
relaxometry.
• Hydrogel parameters of the cHANPs, in other words, mesh size and crosslink density, were computed using 
Flory–Rehner equations and related to the relaxometric properties of the produced nanostructures.
• We pointed out and theoretically demonstrated that Gd-DTPA relaxometric properties can be modulated by 
tuning the hydrogel structure of cHANPs through a microfluidic platform.
• The complex equilibrium established by the elastic stretches of polymer chains, water osmotic pressure and 
hydration degree of Gd-DTPA, able to boost the relaxometric properties of Gd-DTPA, is here defined and 
called Hydrodenticity.
• The new concept is used to explain the increase (12-times) in Gd-DTPA relaxivity, achieved through the 
production of 35 nm cHANPs.
• Within the cHANPs, the properties of Hydrodenticity can be modulated to obtain desired crosslink density, 
mesh size, hydrophilicity and loading capability, playing on the biodegradable behavior and relaxometric 
properties of the Gd-loaded cHANPs.
• The capability to control this equilibrium within the nanoparticles can be applied to define a new class of 
medical devices useful to improve the properties of magnetic resonance imaging CAs.
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